Showing 1 - 14 results of 14 for search 'April W Armstrong', query time: 0.03s Refine Results
  1. 1
    JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis

    JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis by Leeyen Hsu, April W. Armstrong

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010.

    Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010. by Balvinder Rehal, April W Armstrong

    Published 2011-04-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Off-label biologic regimens in psoriasis: a systematic review of efficacy and safety of dose escalation, reduction, and interrupted biologic therapy.

    Off-label biologic regimens in psoriasis: a systematic review of efficacy and safety of dose escalation, reduction, and interrupted biologic therapy. by Elizabeth A Brezinski, April W Armstrong

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes

    Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes by Bruce E. Strober, Michael Bukhalo, April W. Armstrong, David Pariser, Leon Kircik, Brian Johnson, Paul Montgomery, Tobin J. Dickerson

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Comparing antibiotic prescribing patterns for hidradenitis suppurativa between the emergency department and ambulatory care setting

    Comparing antibiotic prescribing patterns for hidradenitis suppurativa between the emergency department and ambulatory care setting by Hannah Tolson, Rebecca K. Yamamoto, Robin Kikuchi, Kaviyon Sadrolashrafi, Audrey Hao, Lily Guo, Sara Bilimoria, Danielle Yee, April W. Armstrong

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    The impact of insurance status on psoriasis patients’ healthcare-seeking behavior: a population-based study in the United States

    The impact of insurance status on psoriasis patients’ healthcare-seeking behavior: a population-based study in the United States by Kaviyon Sadrolashrafi, Audrey Hao, Rebecca K. Yamamoto, Lily Guo, Robin Kikuchi, Hannah C. Tolson, Sara N. Bilimoria, Danielle K. Yee, April W. Armstrong

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Patient-Reported Outcomes by Baseline Body Surface Area Involvement Among Individuals Initiating Biologic Therapy: Results from the CorEvitas Psoriasis Registry

    Patient-Reported Outcomes by Baseline Body Surface Area Involvement Among Individuals Initiating Biologic Therapy: Results from the CorEvitas Psoriasis Registry by April W. Armstrong, Steven R. Feldman, Timothy Fitzgerald, Theodore Alkousakis, Adam Sima, Alvin Li, Hyung-Joo Kang, Sandra I. Main, Saakshi Khattri, Linda Stein Gold

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials

    Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials by April W. Armstrong, Leon Kircik, Linda Stein Gold, Bruce Strober, Claudia H. M. C. De Oliveira, John Vaile, Ying-Ming Jou, Carolin Daamen, Thomas Scharnitz, Mark Lebwohl

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Tapinarof Cream for Adults and Children with Atopic Dermatitis—Efficacy by Race and Fitzpatrick Skin Type in Two Phase 3 Randomized Clinical Trials

    Tapinarof Cream for Adults and Children with Atopic Dermatitis—Efficacy by Race and Fitzpatrick Skin Type in Two Phase 3 Randomized Clinical Trials by Andrew F. Alexis, Leon Kircik, Raj Chovatiya, Zakiya P. Rice, Weily Soong, Tina Bhutani, Philip M. Brown, Stephen C. Piscitelli, David S. Rubenstein, Anna M. Tallman, April W. Armstrong

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Correction to: Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials

    Correction to: Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials by April W. Armstrong, Matthias Augustin, Jennifer L. Beaumont, Tan P. Pham, Stacie Hudgens, Kenneth B. Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M. Kisa, Subhashis Banerjee, Kim A. Papp

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials

    Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials by April W. Armstrong, Matthias Augustin, Jennifer L. Beaumont, Tan P. Pham, Stacie Hudgens, Kenneth B. Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M. Kisa, Subhashis Banerjee, Kim A. Papp

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry

    Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry by Philip J Mease, Jeffrey D Greenberg, Carol J Etzel, William J Huster, Talia M Muram, April W Armstrong, Jeffrey R Lisse, Sabrina Rebello, Rhiannon Dodge, Mwangi James Murage, William N Malatestinic

    Published 2019-06-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Deucravacitinib in Patients with Plaque Psoriasis Who Screened Positive for Psoriatic Arthritis: Improvements in Joint Pain and the Impact of Musculoskeletal Symptoms

    Deucravacitinib in Patients with Plaque Psoriasis Who Screened Positive for Psoriatic Arthritis: Improvements in Joint Pain and the Impact of Musculoskeletal Symptoms by Joseph F. Merola, Philip J. Mease, April W. Armstrong, Vibeke Strand, Thomas Lehman, Stefan Varga, Jiyoon C. Choi, Brandon Becker, Yichen Zhong, Matthew J. Colombo, Diamant Thaçi, Androniki Bili, Alice B. Gottlieb

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials

    Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials by Neil J. Korman, Richard B. Warren, Jerry Bagel, April W. Armstrong, Melinda Gooderham, Bruce Strober, Diamant Thaçi, Akimichi Morita, Shinichi Imafuku, Peter Foley, Howard Sofen, Min Zheng, Lauren Hippeli, Renata M. Kisa, Subhashis Banerjee, Andrew Blauvelt

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: